Spencer Pharmaceutical Inc. Stock Price

OTCPK:SPPH Community·US$271.0 Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

SPPH Share Price Performance

US$0.000001

0.00 (0.00%)

US$0.000001

0.00 (0.00%)

US$0.000001

Fri, 26 Dec 25

Share Pricen/a

SPPH Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks

0 Rewards

View Full Analysis

Spencer Pharmaceutical Inc. Key Details

Last Reported Earnings

Dec 31, 2010

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About SPPH

Founded: 1998
Employees: n/a
CEO: Maximilien Arella
Website: n/a

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.